Prevention of ICU-acquired infection with decontamination regimen in immunocompromised patients: a pre/post observational study
- PMID: 37597052
- DOI: 10.1007/s10096-023-04650-5
Prevention of ICU-acquired infection with decontamination regimen in immunocompromised patients: a pre/post observational study
Abstract
Purpose: Although the proportion of immunocompromised patients admitted to the ICU is increasing, data regarding specific management, including acquired infection (ICU-AI) prophylaxis, in this setting are lacking. We aim to investigate the effect of multiple-site decontamination regimens (MSD) in immunocompromised patients.
Methods: We conducted a prospective pre-/post-observational study in 2 ICUs in Bretagne, western France. Adults who required mechanical ventilation for 24 h or more were eligible. During the study period, MSD was implemented in participating ICUs in addition to standard care. It consists of the administration of topical antibiotics (gentamicin, colistin sulfate, and amphotericin B), four times daily in the oropharynx and the gastric tube, 4% chlorhexidine bodywash once daily, and a 5-day nasal mupirocin course.
Results: Overall, 295 immunocompromised patients were available for analysis (151 in the post-implementation group vs 143 in the pre-implementation group). Solid organ cancer was present in 77/295 patients while immunomodulatory treatments were noticed in 135/295. They were 35 ICU-AI in 29/143 patients in the standard-care group as compared with 10 ICU-AI in 9/151 patients in the post-implementation group (p < 0.001). In a multivariable Poisson regression model, MSD was independently associated with a decreased incidence of ICU-AI (incidence rate ratio = 0.39; 95%CI [0.20-0.87] p = 0.008). There were 35/143 deaths in the standard-care group as compared with 22/151 in the post-implementation group (p = 0.046), this difference remained in a multivariable Cox model (HR = 0.58; 95CI [0.34-0.95] p = 0.048).
Conclusion: In conclusion, MSD appeared to be associated with improved outcomes in critically ill immunocompromised patients.
Keywords: Acquired infection; Bacteremia; Critical care; Immunodepression; Mortality; Pneumonia; Selective decontamination of the digestive tract.
© 2023. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Similar articles
-
Prevention of acquired invasive fungal infection with decontamination regimen in mechanically ventilated ICU patients: a pre/post observational study.Infect Dis (Lond). 2023 Apr;55(4):263-271. doi: 10.1080/23744235.2023.2170460. Epub 2023 Jan 24. Infect Dis (Lond). 2023. PMID: 36694427
-
Multiple-site decontamination to prevent acquired infection in patients with veno-venous ECMO support.Ann Intensive Care. 2023 Apr 7;13(1):27. doi: 10.1186/s13613-023-01120-1. Ann Intensive Care. 2023. PMID: 37024761 Free PMC article.
-
Multiple-site decontamination regimen decreases acquired infection incidence in mechanically ventilated COVID-19 patients.Ann Intensive Care. 2022 Sep 2;12(1):84. doi: 10.1186/s13613-022-01057-x. Ann Intensive Care. 2022. PMID: 36053369 Free PMC article.
-
Topical antibiotic prophylaxis to reduce respiratory tract infections and mortality in adults receiving mechanical ventilation.Cochrane Database Syst Rev. 2021 Jan 22;1(1):CD000022. doi: 10.1002/14651858.CD000022.pub4. Cochrane Database Syst Rev. 2021. PMID: 33481250 Free PMC article.
-
Selective oropharyngeal decontamination versus selective digestive decontamination in critically ill patients: a meta-analysis of randomized controlled trials.Drug Des Devel Ther. 2015 Jul 14;9:3617-24. doi: 10.2147/DDDT.S84587. eCollection 2015. Drug Des Devel Ther. 2015. PMID: 26203227 Free PMC article. Review.
Cited by
-
Multiple-site decontamination in critically ill patients requires careful implementation.Infect Med (Beijing). 2024 Oct 16;3(4):100142. doi: 10.1016/j.imj.2024.100142. eCollection 2024 Dec. Infect Med (Beijing). 2024. PMID: 39559749 Free PMC article.
-
Healthcare-associated infections in the context of the pandemic.Front Health Serv. 2023 Nov 28;3:1288033. doi: 10.3389/frhs.2023.1288033. eCollection 2023. Front Health Serv. 2023. PMID: 38089543 Free PMC article. No abstract available.
References
-
- van Vliet M, Verburg IWM, van den Boogaard M et al (2014) Trends in admission prevalence, illness severity and survival of haematological patients treated in Dutch intensive care units. Intensive Care Med 40:1275–1284. https://doi.org/10.1007/s00134-014-3373-x - DOI - PubMed
-
- Siegel RL, Miller KD, Jemal A (2018) Cancer statistics, 2018. CA Cancer J Clin 68(1):7–30. https://doi.org/10.3322/caac.21442 - DOI - PubMed
-
- Mokart D, Pastores SM, Darmon M (2014) Has survival increased in cancer patients admitted to the ICU? Yes. Intensive Care Med 40:1570–1572. https://doi.org/10.1007/s00134-014-3433-2 - DOI - PubMed
-
- Moreau AS, Martin-Loeches I, Povoa P, Salluh J, Rodriguez A, Thille AW, Diaz Santos E, Vedes E, Lobo SM, Mégarbane B, MoleroSilvero E, Coelho L, Argaud L, Sanchez Iniesta R, Labreuche J, Rouzé A, Nseir S, TAVeM Study Group (2018) Impact of immunosuppression on incidence, aetiology and outcome of ventilator-associated lower respiratory tract infections. Eur Respir J 51(3):1701656. https://doi.org/10.1183/13993003.01656-2017 - DOI - PubMed
-
- Massart N, Reizine F, Fillatre P, Seguin P, La Combe B, Frerou A, Egreteau PY, Hourmant B, Kergoat P, Lorber J, Souchard J, Canet E, Rieul G, Fedun Y, Delbove A, Camus C (2022) Multiple-site decontamination regimen decreases acquired infection incidence in mechanically ventilated COVID-19 patients. Ann Intensive Care 12(1):84. https://doi.org/10.1186/s13613-022-01057-x - DOI - PubMed - PMC
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources